MAP1LC3A and systemic lupus erythematosus: 2) Compare the SLE group before treatment with the traditional treatment group after 6 months of treatment, there was no significant difference in the expression of LC3 protein in peripheral blood lymphocytes, which was not statistically significant ([0.5175 ± 0.0721] vs. [0.5097 ± 0.0911], t = 0.445, P = 0.2).